UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes

Neurology, 2006-10, Vol.67 (7), p.1242-1249

2006

Volltextzugriff (PDF)

Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFIT

Journal of neurology, neurosurgery and psychiatry, 2014-11, Vol.85 (11), p.1183-1189

2014

Volltextzugriff (PDF)

Interferon β-1b-neutralizing antibodies 5 years after clinically isolated syndrome

Neurology, 2011-08, Vol.77 (9), p.835-843

2011

Volltextzugriff (PDF)

Subgroups of the BENEFIT study: Risk of developing MS and treatment effect of interferon beta-1b

Journal of neurology, 2008-04, Vol.255 (4), p.480-487

2008

Volltextzugriff (PDF)

Interferon β-1b and glatiramer acetate effects on permanent black hole evolution

Neurology, 2011-04, Vol.76 (14), p.1222-1228

2011

Volltextzugriff (PDF)

Blockade of chemokine signaling in patients with multiple sclerosis

Neurology, 2006-11, Vol.67 (10), p.1880-1883

2006

Volltextzugriff (PDF)

Evaluation of soluble HLA-G as a biomarker for multiple sclerosis

Neurology, 2011-08, Vol.77 (6), p.596-598

2011

Volltextzugriff (PDF)

Lesional magnetization transfer ratio: a feasible outcome for remyelinating treatment trials in multiple sclerosis

Multiple sclerosis, 2010-06, Vol.16 (6), p.660-669

2010

Volltextzugriff (PDF)

Predictive nature of IgM anti-α-glucose serum biomarker for relapse activity and EDSS progression in CIS patients: a BENEFIT study analysis

Multiple sclerosis, 2012-07, Vol.18 (7), p.966-973

2012

Volltextzugriff (PDF)

Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosis

Neuroradiology, 2010-10, Vol.52 (10), p.875-881

2010

Volltextzugriff (PDF)

Persistent T1 hypointensity as an MRI marker for treatment efficacy in multiple sclerosis

Multiple sclerosis, 2008-07, Vol.14 (6), p.764-769

2008

Volltextzugriff (PDF)

Benefit 11: Long-term follow-up study of patients with clinically isolated syndrome treated with interferon beta-1b

Journal of the neurological sciences, 2013-10, Vol.333, p.e383-e383

2013

Volltextzugriff (PDF)

Body mass index as a predictor of MS activity and progression among participants in BENEFIT

Multiple sclerosis, 2022-07, Vol.28 (8), p.1277-1285

2022

Volltextzugriff (PDF)

Can the functional assessment of multiple sclerosis adapt to changing needs? A psychometric validation in patients with clinically isolated syndrome and early relapsing–remitting multiple sclerosis

Multiple sclerosis, 2011-12, Vol.17 (12), p.1504-1513

2011

Volltextzugriff (PDF)

Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial

Lancet neurology, 2009-11, Vol.8 (11), p.987-997

2009

Volltextzugriff (PDF)

Beta A4-amyloid protein precursor mRNA isoforms without exon 15 are ubiquitously expressed in rat tissues including brain, but not in neurons

The Journal of biological chemistry, 1994-01, Vol.269 (2), p.1510-1517

1994

Volltextzugriff (PDF)

Lack of Association between Antimyelin Antibodies and Progression to Multiple Sclerosis

The New England journal of medicine, 2007-01, Vol.356 (4), p.371-378

2007

Volltextzugriff (PDF)

Elements of informed consent for pharmacogenetic research; perspective of the pharmacogenetics working group

The pharmacogenomics journal, 2002, Vol.2 (5), p.284-292

2002

Volltextzugriff (PDF)

Genes contributing to Alzheimer's disease

Molecular psychiatry, 1996-03, Vol.1 (1), p.27

1996

Volltextzugriff (PDF)

APP Gene Family Alternative Splicing Generates Functionally Related Isoforms

Annals of the New York Academy of Sciences, 1996-01, Vol.777 (1), p.281-287

1996

Volltextzugriff (PDF)

FP36-WE-06 Evaluation of efficacy, safety and tolerability of interferon beta 1b in patients of Chinese origin with multiple sclerosis

Journal of the neurological sciences, 2009, Vol.285, p.S115-S115

2009

Volltextzugriff (PDF)

Similar alternative splicing of a non-homologous domain in beta A4-amyloid protein precursor-like proteins

The Journal of biological chemistry, 1994-05, Vol.269 (19), p.14227-14234

1994

Volltextzugriff (PDF)

Missense mutations of the PS-1/S182 gene in german early-onset Alzheimer's disease patients

Annals of neurology, 1996-08, Vol.40 (2), p.265-266

1996

Volltextzugriff (PDF)

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes

American journal of ophthalmology, 2007, Vol.143 (1), p.194-195

2007

Volltextzugriff (PDF)

Oral interferon beta-1a in relapsing-remitting multiple sclerosis: a double-blind randomized study

Multiple sclerosis, 2003-08, Vol.9 (4), p.342-348

2003

Volltextzugriff (PDF)

1 – 25 von 130

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(125)
Mit Volltextzugriff
(97)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(76)
Life Sciences & Biomedicine
(75)
Humans
(59)
Biological And Medical Sciences
(38)
Neurosciences & Neurology
(37)
Clinical Neurology
(31)
Male
(30)
Adult
(27)
Female
(26)
Medical Sciences
(26)
Neurology
(26)
Neurosciences
(23)
Biochemistry & Molecular Biology
(17)
Interferon Beta-1b
(16)
Interferon-Beta - Therapeutic Use
(16)
Middle Aged
(16)
Multiple Sclerosis
(16)
Animals
(14)
Treatment Outcome
(14)
Fundamental And Applied Biological Sciences. Psychology
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes

Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFIT

Interferon β-1b-neutralizing antibodies 5 years after clinically isolated syndrome

Subgroups of the BENEFIT study: Risk of developing MS and treatment effect of interferon beta-1b

Interferon β-1b and glatiramer acetate effects on permanent black hole evolution

Blockade of chemokine signaling in patients with multiple sclerosis

Evaluation of soluble HLA-G as a biomarker for multiple sclerosis

Lesional magnetization transfer ratio: a feasible outcome for remyelinating treatment trials in multiple sclerosis

Predictive nature of IgM anti-α-glucose serum biomarker for relapse activity and EDSS progression in CIS patients: a BENEFIT study analysis

Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosis

Persistent T1 hypointensity as an MRI marker for treatment efficacy in multiple sclerosis

Benefit 11: Long-term follow-up study of patients with clinically isolated syndrome treated with interferon beta-1b

Body mass index as a predictor of MS activity and progression among participants in BENEFIT

Can the functional assessment of multiple sclerosis adapt to changing needs? A psychometric validation in patients with clinically isolated syndrome and early relapsing–remitting multiple sclerosis

Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial

Beta A4-amyloid protein precursor mRNA isoforms without exon 15 are ubiquitously expressed in rat tissues including brain, but not in neurons

Lack of Association between Antimyelin Antibodies and Progression to Multiple Sclerosis

Elements of informed consent for pharmacogenetic research; perspective of the pharmacogenetics working group

Genes contributing to Alzheimer's disease

APP Gene Family Alternative Splicing Generates Functionally Related Isoforms

FP36-WE-06 Evaluation of efficacy, safety and tolerability of interferon beta 1b in patients of Chinese origin with multiple sclerosis

Similar alternative splicing of a non-homologous domain in beta A4-amyloid protein precursor-like proteins

Missense mutations of the PS-1/S182 gene in german early-onset Alzheimer's disease patients

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes

Oral interferon beta-1a in relapsing-remitting multiple sclerosis: a double-blind randomized study

Suchergebnisse filtern